ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Documenti analoghi

• The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
  di: Gentile, Sandro, et al.
  Pubblicazione: (2020)
• Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
  di: Gentile, Sandro, et al.
  Pubblicazione: (2020)
• Endocrine significance of SARS-CoV-2’s Reliance on ACE2
  di: Chappell, Mark C
  Pubblicazione: (2020)
• ACE2 and SARS-CoV-2 – tissue or plasma, good or bad?
  di: Wenzel, Ulrich O, et al.
  Pubblicazione: (2020)
• ACE2: The Major Cell Entry Receptor for SARS-CoV-2
  di: Scialo, Filippo, et al.
  Pubblicazione: (2020)